Samsung BioLogics Archives | Be Korea-savvy
Samsung Biologics Inks COVID-19 Drug Manufacturing Deal with Eli Lilly

Samsung Biologics Inks COVID-19 Drug Manufacturing Deal with Eli Lilly

SEOUL, Nov. 17 (Korea Bizwire) — South Korean pharmaceutical firm Samsung Biologics Co. said Tuesday it has signed a long-term agreement with U.S. pharmaceutical firm Eli Lilly and Company to manufacture a novel coronavirus-neutralizing antibody. Under the contract manufacturing organization (CMO) agreement, Samsung Biologics will provide Eli Lilly’s investigational neutralizing antibody for the treatment of [...]

Samsung Biologics Inks Manufacturing Deal with AstraZeneca

Samsung Biologics Inks Manufacturing Deal with AstraZeneca

SEOUL, Sept. 22 (Korea Bizwire) — South Korea’s top pharmaceutical firm, Samsung Biologics Co., said Tuesday it has signed a long-term supply agreement, valued at approximately US$330.8 million, with British-Swedish bio giant AstraZeneca Plc. Under the contract manufacturing organization (CMO) agreement, Samsung Biologics will provide large-scale commercial manufacturing for drug substance in its third plant [...]

Samsung Biologics to Spend 1.7 tln Won for 4th Plant amid Growing Demand

Samsung Biologics to Spend 1.7 tln Won for 4th Plant amid Growing Demand

SEOUL, Aug. 11 (Korea Bizwire) — Samsung Biologics, a biopharmaceutical unit of South Korea’s largest conglomerate Samsung Group, said Tuesday that it will build a fourth plant in the country in response to rising manufacturing demand. The 1.7 trillion-won (US$1.4 billion) plant in Songdo, western Incheon, will have a bioreactor capacity of 256,000 liters, the [...]

Samsung Biologics Inks Manufacturing Deal with GSK

Samsung Biologics Inks Manufacturing Deal with GSK

SEOUL, May 22 (Korea Bizwire) — South Korea’s top pharmaceutical firm, Samsung Biologics Co., said Friday it has signed a tieup deal with multinational drug maker GlaxoSmithKline Plc. (GSK) to manufacture a GSK biosimilar product. Under the contract manufacturing organization (CMO) agreement, Samsung Biologics will commercially produce CSK’s lupus treatment, Benlysta, starting in 2022. The [...]

Samsung BioLogics Inks Manufacturing Deal for Coronavirus Treatment

Samsung BioLogics Inks Manufacturing Deal for Coronavirus Treatment

SEOUL, April 10 (Korea Bizwire) — Samsung BioLogics, a biopharmaceutical unit of South Korea’s Samsung Group, said Friday that it has clinched a US$362 million deal to manufacture a candidate treatment for the novel coronavirus. Under the deal, Samsung BioLogics will start full-scale production of U.S. drug firm Vir Biotechnology’s candidate COVID-19 treatment that is [...]

Samsung Electronics President Grilled About Accounting Scandal at Biotech Affiliates

Samsung Electronics President Grilled About Accounting Scandal at Biotech Affiliates

SEOUL, Jun. 11 (Korea Bizwire) — Chung Hyun-ho, president of Samsung Electronics, was questioned by prosecutors on Tuesday about his suspected involvement in alleged accounting fraud at the company’s biotech affiliates. The 59-year-old Chung, known as one of the closest aides to Samsung Electronics Vice Chairman Lee Jae-yong, arrived at the Seoul Central District Prosecutors [...]

Retail Investors Own Over 3 tln Won of Suspended Samsung Biologics

Retail Investors Own Over 3 tln Won of Suspended Samsung Biologics

SEOUL, Nov. 19 (Korea Bizwire) – Retail investors are estimated to hold more than 3 trillion won worth of Samsung BioLogics Co. shares, whose trading was suspended last week over window-dressing, a corporate researcher said Monday. As of last Wednesday, individual investors owned an estimated 9.6 million shares of Samsung BioLogics, or 14.53 percent, according [...]

Samsung BioLogics Expresses Concerns over FSS’s Leak of Sensitive Information

Samsung BioLogics Expresses Concerns over FSS’s Leak of Sensitive Information

SEOUL, May 8 (Korea Bizwire) — South Korea’s major biopharmaceutical firm Samsung BioLogics Co., which has been embroiled in an alleged violation of accounting rules, on Tuesday expressed concern over the financial watchdog’s disclosure of sensitive information. “We express deep concern and regret over the situation where sensitive information surrounding the case, which is under [...]

Samsung Biologics Wins Manufacturing Approval from Europe

Samsung Biologics Wins Manufacturing Approval from Europe

SEOUL, Dec. 13 (Korea Bizwire) — South Korean biopharmaceutical firm Samsung Biologics Co. said Wednesday it has won approval from European health authorities to manufacture drugs at its plant in Europe. The European Medicines Agency (EMA) accepted Samsung Biologics’ manufacturing application to make 152,000 liters of biosimilars at the plant, officials said. The approval comes [...]